Bioactive Glass

Bioactive Glass

Global Bioactive Glass Market to Reach US$3.1 Billion by 2030

The global market for Bioactive Glass estimated at US$1.0 Billion in the year 2023, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 17.3% over the analysis period 2023-2030. Silicate-based Glass, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Phosphate-based Glass segment is estimated at 17.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$268.4 Million While China is Forecast to Grow at 16.2% CAGR

The Bioactive Glass market in the U.S. is estimated at US$268.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$474.1 Million by the year 2030 trailing a CAGR of 16.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 14.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Global Bioactive Glass Market - Key Trends and Drivers Summarized

Bioactive glass is a highly specialized material used primarily in the medical field, particularly in regenerative medicine and tissue engineering. It is composed of silica, calcium, sodium, and phosphorus, which are materials that are known to integrate well with human bone and tissue. The unique property of bioactive glass is its ability to bond with hard and soft tissues, which is crucial in applications such as bone grafting, dental reconstruction, and wound healing. This material is engineered to react in a controlled manner when in contact with biological fluids, leading to the formation of hydroxycarbonate apatite (HCA), which is chemically and structurally similar to human bone mineral. The bioactivity of this glass not only supports bone regrowth but also stimulates angiogenesis, the process of new blood vessel formation, which is essential for the healing of damaged tissues.

Advancements in the formulation and manufacturing of bioactive glass have broadened its application scope, making it a critical component in several cutting-edge medical products. Recent innovations have led to the development of bioactive glass compositions that dissolve at different rates, offering tailored resorption times that match the natural healing processes of various tissues. This capability allows for the use of bioactive glass in complex orthopedic and dental surgeries where precise timing of material degradation and tissue regeneration is crucial. Moreover, bioactive glass is increasingly being combined with other biocompatible materials such as polymers and ceramics to create composite materials that offer enhanced mechanical properties and improved biological performance. Such composites are particularly useful in load-bearing orthopedic applications, where both durability and bioactivity are required.

The growth in the bioactive glass market is driven by several factors, including technological innovations, increasing clinical acceptance, and expanding applications in the medical field. The continuous improvement in glass formulations and processing techniques has resulted in products that offer better performance and greater versatility, catering to a broader range of medical procedures. Clinical studies validating the efficacy and benefits of bioactive glass in tissue regeneration and infection control have bolstered its adoption among healthcare providers. Additionally, there is a growing trend of personalized medicine where materials like bioactive glass are used to develop customized solutions for individual patients, further propelling market growth. Economic factors, such as the rising healthcare expenditure globally and the increasing investment in biomedical research, also play significant roles in the expansion of this market. These elements collectively ensure that the demand for bioactive glass remains robust, reflecting its critical role in advancing medical treatments and improving patient outcomes.

Select Competitors (Total 39 Featured) -

• Arthrex, Inc
• BioMin Technologies Limited
• Bonalive Biomaterials Ltd
• DePuy Synthes
• LASAK s.r.o.
• Matexcel
• Mo-Sci Corporation
• NanoFUSE Biologics LLC
• Noraker
• NovaBone Products LLC
• Schott AG
• Stryker Corporation
• Synergy Biomedical, LLC
• SynThera Biomedical Pvt. Ltd
• Vedayukt India Private Limited;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.